PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.\', \'Department of Hematology and.\', \'Department of Endocrinology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.\', \'Division of Experimental Oncology, Università Vita-Salute San Raffaele, IRCCS Ospedale San Raffaele, Milan, Italy.\', \'European Research Initiative on CLL (ERIC), Barcelona, Spain; and.\', \'Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center-Weill Cornell College of Medicine, New York, NY.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1182/blood.2021011568
?:hasPublicationType
?:journal
  • Blood
is ?:pmid of
?:pmid
?:pmid
  • 33861303
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.434
?:rankingScore_hIndex
  • 410
is ?:relation_isRelatedTo_publication of
?:title
  • Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33861303>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33861303>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all